ARV-6723

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsNCT07749586ARVNPhase 1, Phase 2Recruiting2031-03-31Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.